搜索临床试验以:福莫特罗 12 微克,每天两次
总计810个结果
-
Hal ChapmanMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI); University... 和其他合作者招聘中
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...终止
-
Beni-Suef UniversityCairo University未知
-
The Leeds Teaching Hospitals NHS TrustLeeds and York Partnership NHS Foundation Trust未知
-
Rush University Medical CenterMerck Sharp & Dohme LLC撤销
-
Khon Kaen UniversityNational Research Council of Thailand完全的癌症 | 中性粒细胞减少症 | 发烧
-
Tel-Aviv Sourasky Medical CenterTel Aviv Medical Center完全的
-
Tempest Therapeutics主动,不招人大肠癌 | 实体瘤 | 胃腺癌 | 非小细胞肺癌 | 头颈部鳞状细胞癌 | 子宫内膜癌 | 尿路上皮癌 | 胃食管结合部腺癌 | 具有 PIK3Ca 突变的实体瘤美国
-
AbbVie (prior sponsor, Abbott)完全的
-
Khondrion BVJulius Clinical; ProPharma Group; Certara完全的线粒体疾病 | 线粒体 DNA tRNALeu(UUR) m.3243A | 母系遗传性糖尿病和耳聋 (MIDD) | 线粒体脑肌病、乳酸性酸中毒和中风样发作 (MELAS) | 慢性进行性外眼肌麻痹 (CPEO)荷兰, 丹麦, 英国, 德国
-
AstraZeneca完全的COPD 方法评估 | 慢性阻塞性肺疾病方法评价英国, 瑞典
-
AstraZeneca完全的
-
AbbVie (prior sponsor, Abbott)完全的
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Hangzhou Yirui Pharmaceutical Technology Co., Ltd完全的
-
University Hospital, BordeauxGrant Agreement ERC n°715093; University of Bordeaux - mission UB-C19完全的
-
National University Hospital, Singapore尚未招聘
-
Hospital Authority, Hong KongThe University of Hong Kong完全的
-
Ottawa Heart Institute Research Corporation暂停
-
Boehringer Ingelheim完全的12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD肺部疾病,慢性阻塞性德国, 意大利, 瑞士, 南非